Global Brachytherapy Market Size & Trends Report Segmented by Dosage Type (HDR, LDR), Product (Afterloaders, Seeds, Applicators & Needles, Electronic Systems), Application (Cancer -Prostate, Cervical, Breast), End User (Hospitals, ASCs) & Regional Forecasts to 2030
The global brachytherapy market is set to witness a growth rate of ~7% in the next 5 years. Rising global cancer burden, clinical benefits and minimally invasive nature of brachytherapy, technological advancements in brachytherapy, and government initiatives and funding for cancer research are some of the key factors driving the brachytherapy market. To learn more about the research report, download a sample report.
Report Overview
Brachytherapy is a form of internal radiation therapy where radioactive sources are placed directly inside or near a tumor, delivering high doses of radiation with minimal impact on surrounding healthy tissues. It is commonly used to treat cancers such as prostate, cervical, breast, and skin cancers among others. Brachytherapy can be administered in different modalities, including low-dose rate (LDR) and high-dose rate (HDR) techniques. This targeted approach allows for shorter treatment durations, fewer side effects, and improved patient outcomes. Advancements in imaging and AI-driven planning have further enhanced its precision, making it an increasingly important component of modern cancer treatment.
To learn more about this report, download the PDF brochure
Rising global cancer burden to propel market demand
The rising global cancer burden is a major driver of the brachytherapy market, as increasing cancer incidence boosts demand for effective, targeted treatments. Prostate, cervical, and breast cancers, which are the key indications for brachytherapy, are becoming more prevalent due to aging populations, lifestyle factors, and environmental risks. Brachytherapy’s ability to deliver high radiation doses with minimal healthy tissue damage makes it a preferred option for many patients. Additionally, healthcare systems worldwide are expanding oncology infrastructure, increasing investment in radiation therapy, and improving access to advanced treatments, further fueling the adoption of brachytherapy as a crucial component of cancer care.
Clinical benefits and minimally invasive nature of brachytherapy are driving the market growth
The clinical benefits and minimally invasive nature of brachytherapy are key drivers of its market growth. Unlike traditional radiation therapies, brachytherapy delivers highly localized radiation, minimizing damage to surrounding healthy tissues and reducing side effects. This precision improves treatment outcomes, particularly for prostate, cervical, and breast cancers. Additionally, brachytherapy is often performed as an outpatient procedure, leading to shorter hospital stays, faster recovery times, and lower healthcare costs. Its minimally invasive nature makes it an attractive option for elderly patients or those with comorbidities, further increasing its adoption and fueling market expansion in modern oncology care.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global brachytherapy market is marked by the presence of established and emerging market players such as Elekta; Varian Medical Systems (A Siemens Healthineers Company); Theragenics Corporation; Becton, Dickinson and Company (BD); Eckert & Ziegler; Ariane Medical Systems Ltd; CIVCO Medical Solutions; Sun Nuclear Corporation; IsoAid, LLC; and Best Medical International, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
|
Report Metric |
Details |
|
Base Year Considered |
2024 |
|
Historical Data |
2023 – 2024 |
|
Forecast Period |
2025 – 2030 |
|
Growth Rate |
7% |
|
Market Drivers |
|
|
Attractive Opportunities |
|
|
Segment Scope |
Dosage Type, Product, Application, End User |
|
Regional Scope |
|
|
Key Companies Mapped |
Elekta; Varian Medical Systems (A Siemens Healthineers Company); Theragenics Corporation; Becton, Dickinson and Company (BD); Eckert & Ziegler; Ariane Medical Systems Ltd; CIVCO Medical Solutions; Sun Nuclear Corporation; IsoAid, LLC; and Best Medical International, Inc.; among others |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Brachytherapy Market Segmentation
This report by Medi-Tech Insights provides the size of the global brachytherapy market at the regional- and country-level from 2023 to 2030. The report further segments the market based on dosage type, product, application, end user.
Market Size & Forecast (2023-2030), By Dosage Type, USD Million
- High-Dose Rate (HDR)
- Low-Dose Rate (LDR)
Market Size & Forecast (2023-2030), By Product, USD Million
- Afterloaders
- Seeds
- Applicators & Needles
- Electronic Brachytherapy Systems
Market Size & Forecast (2023-2030), By Application, USD Million
- Prostate Cancer
- Cervical Cancer
- Breast Cancer
- Others
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Specialty Clinics & Cancer Treatment Centers
- Ambulatory Surgical Centers (ASCs)
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the brachytherapy market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the brachytherapy market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Brachytherapy Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising global cancer burden
- Clinical benefits and minimally invasive nature of brachytherapy
- Technological advancements in brachytherapy
- Government initiatives and funding for cancer research
- Restraints
- High capital investment and operational costs
- Shortage of trained personnel
- Competition from alternative modalities
- Regulatory and reimbursement challenges
- Opportunities
- Emerging markets and expanding healthcare infrastructure
- Technological innovation and integration
- Personalized and precision medicine
- Collaborative initiatives and strategic partnerships
- Key Market Trends
- Increasing adoption of image-guided brachytherapy (IGBT)
- Integration of brachytherapy with immunotherapy and other combination treatments
- Development of novel radioactive isotopes for enhanced treatment efficacy
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Brachytherapy Market Size & Forecast (2023-2030), By Dosage Type, USD Million
- Introduction
- High-Dose Rate (HDR)
- Low-Dose Rate (LDR)
- Global Brachytherapy Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Afterloaders
- Seeds
- Applicators & Needles
- Electronic Brachytherapy Systems
- Global Brachytherapy Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Prostate Cancer
- Cervical Cancer
- Breast Cancer
- Others
- Global Brachytherapy Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Hospitals
- Specialty Clinics & Cancer Treatment Centers
- Ambulatory Surgical Centers (ASCs)
- Others
- Global Brachytherapy Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Brachytherapy Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Brachytherapy Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Brachytherapy Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Brachytherapy Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Brachytherapy Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Dosage Type (USD Million)
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Elekta
- Varian Medical Systems (A Siemens Healthineers Company)
- Theragenics Corporation
- Becton, Dickinson and Company (BD)
- Eckert & Ziegler
- Ariane Medical Systems Ltd
- CIVCO Medical Solutions
- Sun Nuclear Corporation
- IsoAid, LLC.
- Best Medical International, Inc.,
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Introduction, Hospitals and Clinics, Specialty Clinics & Cancer Treatment Centers, Ambulatory Surgical Centers (ASCs); and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
